Published in Mediterr J Hematol Infect Dis on October 24, 2011
Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome. World J Radiol (2014) 0.88
How I treat children and adolescents with acute promyelocytic leukaemia. Br J Haematol (2013) 0.82
Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo. Oncotarget (2016) 0.78
The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid. Cell Cycle (2014) 0.76
HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells. Oncotarget (2017) 0.75
Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia. Rev Bras Hematol Hemoter (2012) 0.75
Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study. Rev Bras Hematol Hemoter (2016) 0.75
Pseudo differentiation syndrome. Mediterr J Hematol Infect Dis (2011) 0.75
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood (1988) 6.09
Acute promyelocytic leukemia: from highly fatal to highly curable. Blood (2008) 5.35
The acute respiratory distress syndrome. N Engl J Med (1995) 5.24
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol (2001) 3.24
The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med (1992) 2.99
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer (2010) 2.66
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. J Clin Oncol (2008) 2.54
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood (2008) 2.04
How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer (2002) 1.93
Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant (2001) 1.81
Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood (2009) 1.74
Neutrophil adhesion and activation under flow. Microcirculation (2009) 1.67
The role of neutrophil elastase in acute lung injury. Eur J Pharmacol (2002) 1.62
Role of interleukin-8 and growth-regulated oncogene-alpha in the chemotactic migration of all-trans retinoic acid-treated promyelocytic leukemic cells toward alveolar epithelial cells. Crit Care Med (2007) 1.42
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood (2000) 1.41
Proteases and lung injury. Crit Care Med (2003) 1.27
Retinoic acid syndrome: manifestations, pathogenesis, and treatment. Best Pract Res Clin Haematol (2003) 1.19
Acute promyelocytic leukemia: a paradigm for differentiation therapy. Cancer Treat Res (2010) 1.10
All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol (2001) 1.09
Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia. Br J Haematol (2010) 0.96
Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2. Blood (1997) 0.95
Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia. Haematologica (2007) 0.94
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial. Leukemia (2003) 0.94
An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid. Hematol Oncol (2004) 0.92
Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Med Oncol (2009) 0.92
The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia. J Leukoc Biol (2007) 0.90
Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line. Leukemia (2004) 0.89
High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia. Leuk Res (2009) 0.89
Monocyte chemotactic protein-1 in the migration of differentiated leukaemic cells toward alveolar epithelial cells. Eur Respir J (2008) 0.88
Cardiac stunning as a manifestation of ATRA differentiation syndrome in acute promyelocytic leukemia. Med Oncol (2011) 0.83
Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells. Leuk Res (2005) 0.83
Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two cases. Eur J Haematol (2006) 0.81
All-trans retinoic acid-induced focal myositis, synovitis, and mononeuritis. J Clin Rheumatol (2009) 0.80
[Hematological features and expression profile of myeloid antigens of acute promyelocytic leukemia patients: analysis of prognostic factors for development of the retinoic acid syndrome]. Rev Assoc Med Bras (2004) 0.77
Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Med Oncol (2009) 0.92
Epidemiology and treatment of acute promyelocytic leukemia in latin america. Mediterr J Hematol Infect Dis (2011) 0.82
Mobilization and harvesting of PBPC in newly diagnosed type 1 diabetes mellitus. Bone Marrow Transplant (2011) 0.75